Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Therapeutic goods regulation (38)
- Manufacturing (26)
- Regulatory compliance (26)
- Unique Device Identification (UDI) hub (20)
- In Vitro Diagnostic medical devices (IVDs) (19)
- Prescription medicines (17)
- Safety (10)
- Clinical trials (9)
- Medical devices safety (9)
- Australian Register of Therapeutic Goods (ARTG) (8)
- Legislation (8)
- Medicine safety (8)
- Vaping hub (8)
- Scheduling (national classification system) (7)
- Medicinal cannabis hub (5)
- Over the counter (OTC) medicines (5)
- Advertising (4)
- Listed medicines (4)
- Non-prescription medicines (3)
- Shortages (3)
- Breast implant hub (2)
- Complementary medicines (2)
- Compliance and enforcement hub (2)
- Pharmacovigilance (2)
- Advanced therapies (1)
- Advisory bodies and committees (1)
- Alert/Advisory (1)
- Cosmetics (1)
- COVID-19 vaccines (1)
- Import and export (1)
- Labelling and packaging (1)
- TGA conformity assessment certification (1)
Search
200 result(s) found, displaying 101 to 125
-
WebinarsThe purpose of this webinar was to help sponsors understand how to use the Listed Medicines Evidence Guidelines to compile a robust evidence package that supports the efficacy of their listed medicine.
-
PresentationsPresentation at the RACI Pharmaceutical Science Group (NSW) Seminar/Webinar, information for manufacturers of medicinal products on Computerised Systems - establishing and maintaining data integrity
-
WebinarsA webinar covering how to view and respond to notifications in the Consent for Non-compliance Dashboard
-
PresentationsThis webinar will cover the process of submitting evidence of compliance with the EPs for devices in a consent application in a live demonstration.
-
WebinarsA webinar covering medical device that are non-compliant with the Essential Principles (EPs)
-
PresentationsThis webinar will guide you through the process of applying for consent to import, supply or export a medical device non-compliant with the Essential Principles (EPs)
-
PresentationsGuest speakers from Zebra Technologies will share observations and learnings from the UK Scan4Safety pilot.
-
WebinarsGuest speakers from Zebra Technologies will share observations and learnings from the UK Scan4Safety pilot.
-
WebinarsThis webinar provides information on the third UDI Consultation Paper and runs through the submission process. It also includes a project update and question-and-answer session.
-
WebinarsUnderstand the key findings of the independent expert report on the risks of intentional self-poisoning with paracetamol and have your questions answered about the TGA’s consultation (starting mid-September) on the possible options for changing access or purchasing controls through the Poisons Standard.
-
PresentationsA webinar on the key findings from the independent expert report on the risks of intentional self-poisoning with paracetamol and options for amending the Poisons Standard
-
WebinarsInsight into the role and expectations of committee members.
-
WebinarsInformation for manufacturers, sponsors and users of the UDI data on how to access the AusUDID Sandpit
-
PresentationsInformation for manufacturers, sponsors and users of the UDI data on how to access the AusUDID Sandpit
-
WebinarsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit
-
PresentationsTo raise awareness and engage with potential website users about the TGA website redevelopment and release.
-
Unique Device Identification Webinar #10 – Accessing and using the Australian UDI database 'Sandpit'
PresentationsInformation for manufacturers, sponsors and users of UDI data on how to access the AusUDID Sandpit. -
PresentationsSignificant safety issue reporting - Changes to the Pharmacovigilance guidelines for sponsors.
-
PresentationsImproving healthcare with data collected from medicine and vaccine adverse event reporting.
-
PresentationsReal world evidence in the regulation of medical devices.
-
PresentationsA presentation on current activities, collaborations, and performance of the Prescription Medicine Authorisation Branch.
-
PresentationsPost Market Surveillance - Considerations for medial device sponsors.
-
PresentationsThe increasing availability of Real World Evidence presents opportunities to improve treatments and repurpose medicines.
-
PresentationsUpdates on regulatory framework and key activities from the TGA's Medical Devices Authorisation Branch.
-
PresentationsUpdates on regulatory pathways for gene therapy products in Australia.